Dr. J.B. Brown was a post-bachelor researcher at the US National Institutes of Health in 2013 after completing dual degrees in computer science and mathematics at the University of Evansville in the United States.
At NIH he contributed to the development of virtual colonoscopy for routine clinical application.
At the end of 2013, J.B. was selected by the Japanese government for a full graduate school scholarship, and moved to Kyoto University in 2004.
There, he completed his M.S. and Ph.D. degrees in bio- and chemo- informatics in 2010.
As a post-doc from 2010 to 2013 at Kyoto University's Graduate School of Pharmaceutical Sciences, he wrote many articles on computational chemogenomics for drug discovery which have been frequently cited.
Since 2014 he has been a faculty member in Kyoto University's Graduate School of Medicine, where he is involved in both clinical research and continued development of computational methods for drug discovery.
At the same time, since 2014 he has volunteered as the official facilitator of the JCUP drug discovery event held in Tokyo (primary organizer: OpenEye Scientific Software), participating as a scientist, speaker, coordinator, and Japanese-English interpreter.
Based on his contributions to both informatics and medical life science research, in 2015 he was awarded a permanent, independent position within the Graduate School of Medicine, and now runs the Life Science Informatics Research Unit, with research topics including drug discovery, clinical informatics, and next-generation sequencing data processing and interpretation.
Aside from research, J.B. spends his time with his wife and two children ages 1 and 3, and enjoys watching the games of his brother who is a professional football/soccer player.
Sheng-Yong Yang, Dr., Professor of the State Key Laboratory of Biotherapy, West China Hospital, Sichuan University (Sichuan, China). Dr. Yang obtained his PhD degree from Sichuan University in 1999. After that, he did his postdoc research in Hongkong University of Science and Technology from 1999-2001. In 2002-2005, he joined Prof. Tom Ziegler’s group (University of Calgary, Alberta, Canada) as a research scientist. In the end of 2005, he was recruited as a professor of the State Key Laboratory of Biotherapy, West China Hospital, Sichuan University. His research spans methodology of computer aided drug discovery (CADD), and research and development (R&D) of small molecule targeted drugs. Up to now, Dr. Yang has published more than 160 papers in international journals, including JACS, Angew chem Int Ed, Leukemia, Drug Disc Today, JMC, Clin Cancer Res, and JCIM et al. He has developed a number of CADD methods, including PhDD, RASA, SCADMET, GA-CG-SVM, ID-score, and TarPred. Five drug candidates have been transferred to pharmaceutical companies, and one has entered clinical trials. Dr. Yang was awarded the Cheung Kong Scholar of the Ministry of Education (MOE), and won the Life and Chemistry Research Award of Wuxi Pharma Tech in 2012. He received the National Science Fund for Distinguished Young Scholars in 2013.
Until the 2017 Congress!
|Abstract submission opens Now Open|
|Registration opens Now Open|
|Abstract submission closes 23 March 2017|
|Early bird registration deadline 23 April 2017|
|RACI Centenary Congress 23-28 July 2017|